Description
Subscription to La Merie
Publishing’s proprietary Antibody Database provides online access to
information about more than 2,400 project entries for therapeutic antibodies on
the market and in research & development. Pre-established and free search
functions allow to identify antibodies according to their
- Technology (e.g. antibody-drug
conjugate, bispecific, isotype, phage display)
- Target (e.g. Her2, CD20, TNF,
PD-1/PD-L1)
- Pipelines (selected by target,
therapeutic area, company, technology)
- Sales (for marketed antibodies)
- R&D Phase (clinical phases,
market, preclinical)
- Territory (countrywise)
- Therapeutic Area (e.g.
infectious, oncology, gastrointestinal)
- Drug Code/Name (for individual
molecules)
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/antibody-target-technology-and-pipeline-database
Project listing in a tabular format:
- Drug Codes
- Target
- Class of Compound
- Company
- Territory
- Therapeutic Area
- Indication
- R&D Phase
Therapeutic Areas:
- Cardiovascular & blood
- Dermatology
- Gastrointestinal
- Genitourinary, renal & gynecology
- Infectious & toxicology
- Metabolism & endocrine
- Neurology & psychiatry
- Oncology
- Ophthalmology & otorhinolaryngology
- Orthopedics, dental, anesthesia & surgery
- Pulmonary & respiratory
- Rheumatoid & autoimmune
Predefined Technologies of the Scroll-Down Menu - examples:
- Antibody-Drug Conjugates per Payload (e.g. Auristatin, PBD)
- Bispecific Antibodies
- Oligo- and Polyclonal Antibodies
- In vitro generated Antibodies (phage display)
- Fab Antibodies
- Fc-Fusion Proteins
- Agonist Antibodies
- Transgenic Mouse Antibodies (e.g. XenoMouse, VelocImmune Mouse, KM Mouse)
- Human Cell-Derived Antibodies
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll Free:
866-997-4948
No comments:
Post a Comment